Abstracts

Present your research at the Congress:
submit your abstract


The abstract submission opens on October 26, 2021
  • CHECK THE TOPICS
  • COMPOSE ABSTRACT
  • SUBMISSION
  • PRESENTATION

CHECK THE CONGRESS TOPICS:

  • General menopause
  • Epidemiology, basic science and clinical research
  • Diagnosis of menopause
  • Symptoms of menopause including vasomotor symptoms
  • Biochemical prediction of age at menopause
  • Hormone and non-hormonal therapy
  • Premature ovarian insufficiency
  • The menopause after cancer
  • Menopause and COVID-19
  • Menopause in the work place
  • Vulvovaginal atrophy/genitourinary syndrome of menopause
  • Vulvovaginal atrophy/genitourinary syndrome of menopause
  • Treatment options (including vaginal estrogens and laser)
  • Dermatogynecology
  • Microbiota and urogenital health
  • Lower urinary tract symptoms including incontinence ad recurrent UTIs
  • Pelvic organ prolapse
  • Hormones and hormone action
  • Hormones and hormone receptor signaling mechanisms
  • Biological actions of sex steroids
  • Selective hormone receptor modulators
  • Novel treatments and regimens
  • Hormones and metabolism
  • Obesity
  • Metabolic syndrome
  • Insulin resistance, diabetes and dyslipidemia
  • Other topics related to hormones and the metabolism
  • Sexual function
  • Epidemiology, basic science and clinical research
  • Treatment options – psychological and medical approaches
  • Menopause and cardiovascular system
  • Epidemiology, basic science and clinical research
  • Hormones and coronary heart disease
  • Hormones and thrombosis
  • Hormones and cerebrovascular disease
  • Menopause and the brain
  • Neurosteroids and actions
  • Cognitive function
  • Sleep and sleep disorders
  • Alzheimer’s disease and other neurodegenerative disorders
  • Mood and mental disorders
  • Epidemiology, basic science and clinical research
  • Hormonal and non-hormonal treatment of mood disorders (including perimenopausal and premenstrual depression)
  • Schizophrenia and other mental disorders
  • Musculoskeletal health
  • Prevalence, epidemiology and consequences of fragility fracture
  • Bone loss and osteoporosis
  • Sarcopenia
  • Pharmacological and non-pharmacological fracture prevention
  • Breast health
  • Breast and breast cancer biology
  • Breast cancer epidemiology
  • Hormone therapy and breast cancer
  • Imaging in breast cancer (screening and diagnostic)
  • Breast cancer prevention (life style/pharmacotherapy)
  • Tolerance and aromatase inhibitor-related side effects
  • Adjuvant bisphosphonates
  • Gynecology
  • Abnormal uterine bleeding
  • Management of fibroids – medical and surgical
  • Endometriosis (in perimenopause and consequences of surgery)
  • PCOS – implications for menopause
  • Endometrial hyperplasia and cancer
  • Vulval and vaginal conditions
  • Diagnostic gynecology
  • Other oncology
  • Hormones and non-gynecological cancer
  • Screening, diagnosis and treatment of women
  • Treatment consequences in relation to the menopause
  • Novel non hormonal treatment regimens
  • Women at high genetic risk of female cancers e.g. BRCA, Lynch syndrome
  • Other health issues
  • Autoimmune disorders
  • Neurological conditions
  • Sensory functions

PREPARE YOU ABSTRACT ACCORDING TO THE GUIDELINES

  • Divide into sections
    Abstracts should be structured into the following sections if applicable: Context – Objective – Methods – Patient(s) – Intervention(s) – Main Outcome Measure(s) – Result(s) – Conclusions.
  • Abstract limits
    The abstract cannot be longer than 2500 characters including spaces, and must be plain text. It is not possible to include tables and images, but you may insert data in the text of the abstract.
  • Works already presented
    It is possible to submit abstracts already presented.
  • Maximum 2 abstracts
    Submit a maximum of two abstracts on the congress’ topics as presenting author. There is no limit to the number of abstracts submitted as co-author
  • Editing
    Once accepted, abstract cannot be modified in any of its parts (authors, content and title).

Submit and wait for the acceptance

  • Abstract’s submission deadline is on 21 June 2022 
  • The submitted abstracts will be under a blind review process; The presenting authors of accepted abstracts  will be notified by  25 July 2022 whether their abstract is accepted.
  • Speakers whose abstracts have been accepted must complete their congress registration before 24 August 2022; failure to do so will result in exclusion from the Scientific Program.

Present your work at the IMS Congress

Rules for presentation will be available in fall 2022